Case Study: Takeda Pharmaceuticals achieves stronger supply continuity and visibility with Armis

Armis Helps Ensure Ongoing Delivery of Critical Therapeutics to Patients

Takeda Pharmaceuticals, a global biopharmaceutical company operating 45 manufacturing plants across 20 countries, needed better visibility and security across a highly distributed, mixed-age industrial environment. As cyberattacks increasingly threatened intellectual property, production equipment, and supply continuity, Takeda turned to Armis and its Asset Intelligence Platform to help identify and monitor connected assets that could not be covered by agent-based tools.

Armis delivered rapid visibility and ongoing monitoring across Takeda’s manufacturing network, revealing far more devices than expected and helping the company uncover potential cyber risks. Within about six weeks, Takeda identified more than 42,000 devices globally, including 18,000 critical to manufacturing, and gained 100% visibility into connected assets in the manufacturing environment. With Armis, Takeda improved uptime, reduced unplanned downtime, strengthened compliance efforts, and created a single, cloud-based asset repository and dashboard for better operational control.

Takeda Pharmaceuticals

Mike Towers

Chief Infomation Security Officer